Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Ioflupane I-123 is a radiopharmaceutical used in single photon emission computed tomography (SPECT) brain imaging to help diagnose patients with suspected Parkinsonian syndromes. A product used in medical brain imaging to help healthcare providers diagnose Parkinson's Disease.
- Mechanism
- Curator reviewed
Iodine-123 labeled ioflupane binds to presynaptic dopamine transporters. When Iodine-123 decays, a gammay ray is emmitted and detected through SPECT.
- Primary indication
- Ioflupane I-123 is a SPECT (single photon emission computerized tomography) agent used to distinguish between Parkinson’s syndrome tremors and essential tremor.Curator reviewed · 1 structured indication
- Formula / weight
- C18H23FINO2 · 427.291 g/mol (avg)
- First approval
- United States, 2011 · European Union, 2016
- Also known as
- 123I-FP-CIT · 123I-Ioflupane · Iodine ioflupane (123I) · Ioflupane (123I) · Ioflupane I 123
- Brand names
- Datscan
- Striascan
Resolves to
Clinical / RWD
Structure
InChIKey
HXWLAJVUJSVENX-HFIFKADTSA-NSMILES[H][C@]12CC[C@]([H])([C@H]([C@H](C1)C1=CC=C([123I])C=C1)C(=O)OC)N2CCCFTargets
Transporters
What you can answer from here — as of March 03, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Ioflupane I-123, and which of those have an active Phase 3 trial?